info@epichembio.eu + 34 986 812 316

Kancera AB Project Director

johan.schultz@kancera.com
www.kancera.com/sv/Om-oss/Ledning/
Address
Kancera AB. Karolinska Institutet Science Park Banvaktsvägen 22 SE-17148 Solna
Sweden
Keywords

pharmaceutical industry management, evaluation EU-funded research, HDAC6 inhibitors

Models

Techniques

Collaborations outside COST

Short description of ongoing research projects

Kancera runs two small molecule drug discovery projects with epigenetic target proteins: 1. HDAC6 inhibitors against cancer 2. Histone modifying enzyme inhibitors against parasitic diseases (EU-financed A-PARADDISE project). SWElife. DEVELOPMENT OF ANTI-CANCER CANDIDATE DRUG WITH UNIQUE MECHANISM OF ACTION

Publications
Other activities of potential interest to others


Cost UE